Literature DB >> 9884581

[A resected case of malignant peripheral nerve sheath tumor (MPNST) necessary to distinguish from Askin tumor].

M Odaka1, S Yamazaki, T Akiba, R Mizuno, T Harada, Y Yamazaki.   

Abstract

We have treated a patient with malignant peripheral nerve sheath tumor (MPNST) for 7 years by interdisciplinary therapy. The diagnosis and treatment are reported with the clinical course so far. A 20-year-old man underwent surgical resection of a tumor on the left side of the chest in 1990, and a diagnosis of Askin tumor was made. In 1993, the disease recurred in the left axilla and was surgically resected. The surgical specimen was investigated histologically, and a diagnosis of MPNST was made instead of Askin tumor. Recently, a tumor began to grow in the left pleural cavity and was surgical resected. The tumor tissue contained both cells with oval and long spindle nuclei, which were intermingled with each other. Immunohistochemically, the tumor cells were positive for vimentin and some of them were positive for S100 protein. Because electron microscopy showed cytoplasmic processes on the tumor cell and basal lamina-like structures, a diagnosis of recurrent MPNST was made. Because this lesion resembled Askin tumor in its clinical manifestations and histological characteristics, differential diagnosis from Askin tumor was necessary. When a malignant soft tissue tumor arising from the mediastinum or chest walls is detected, immunohistochemical and electron microscopic studies should be performed. The diagnosis should be based on the overall findings including the location and clinical data.

Entities:  

Mesh:

Year:  1998        PMID: 9884581     DOI: 10.1007/bf03217905

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  16 in total

1.  Malignant Schwannoma associated with von Recklinghausen's neurofibromatosis.

Authors:  J G Guccion; F M Enzinger
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-07-27

2.  Malignant peripheral nerve sheath tumors of the buttock and lower extremity. A study of 43 cases.

Authors:  R H Hruban; M H Shiu; R T Senie; J M Woodruff
Journal:  Cancer       Date:  1990-09-15       Impact factor: 6.860

3.  Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases.

Authors:  B S Ducatman; B W Scheithauer; D G Piepgras; H M Reiman; D M Ilstrup
Journal:  Cancer       Date:  1986-05-15       Impact factor: 6.860

4.  Malignant schwannoma. A clinicopathologic study.

Authors:  B C Ghosh; L Ghosh; A G Huvos; J G Fortner
Journal:  Cancer       Date:  1973-01       Impact factor: 6.860

5.  Histopathologic and immunohistochemical study of malignant tumors of peripheral nerve sheath (malignant schwannoma).

Authors:  H Matsunou; T Shimoda; S Kakimoto; H Yamashita; E Ishikawa; M Mukai
Journal:  Cancer       Date:  1985-11-01       Impact factor: 6.860

6.  A consecutive series of 30 malignant schwannomas. Survival in relation to clinico-pathological parameters and treatment.

Authors:  M Bojsen-Møller; O Myhre-Jensen
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1984-05

7.  Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases.

Authors:  J E Wanebo; J M Malik; S R VandenBerg; H J Wanebo; N Driesen; J A Persing
Journal:  Cancer       Date:  1993-02-15       Impact factor: 6.860

8.  Pathologic features of extraosseous Ewing's sarcoma: a report from the Intergroup Rhabdomyosarcoma Study.

Authors:  H Shimada; W A Newton; E H Soule; S J Qualman; C Aoyama; H M Maurer
Journal:  Hum Pathol       Date:  1988-04       Impact factor: 3.466

9.  Peripheral nerve sheath tumors: an electron microscopic study of 43 cases.

Authors:  R A Erlandson; J M Woodruff
Journal:  Cancer       Date:  1982-01-15       Impact factor: 6.860

10.  Malignant peripheral nerve-sheath tumors (malignant schwannomas). An immunohistochemical study of 29 cases.

Authors:  Y Daimaru; H Hashimoto; M Enjoji
Journal:  Am J Surg Pathol       Date:  1985-06       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.